Modulating the unique NADPH homeostasis of cancer cells might be an effective strategy to eliminate these cells
Members access detailed protocols, dosing guides, and a community of experienced researchers navigating these decisions
This product is proudly made in the Philippines, and is available in two sizes
Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1
This groundbreaking formula helps to turn off hunger signals and defend against late-night snacking
Clinical studies have shown that Tesamorelin significantly reduces abdominal fat, particularly in individuals with obesity or HIV-associated lipodystrophy